======= FXYD5 ======= == Gene Information == * **Official Symbol**: FXYD5 * **Official Name**: FXYD domain containing ion transport regulator 5 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=53827|53827]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q96DB9|Q96DB9]] * **Interactions**: [[https://thebiogrid.org/search.php?search=FXYD5&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20FXYD5|Open PubMed]] * **OMIM**: [[https://omim.org/entry/606669|Open OMIM]] == Function Summary == * **Entrez Summary**: This gene encodes a member of a family of small membrane proteins that share a 35-amino acid signature sequence domain, beginning with the sequence PFXYD and containing 7 invariant and 6 highly conserved amino acids. The approved human gene nomenclature for the family is FXYD-domain containing ion transport regulator. Mouse FXYD5 has been termed RIC (Related to Ion Channel). FXYD2, also known as the gamma subunit of the Na,K-ATPase, regulates the properties of that enzyme. FXYD1 (phospholemman), FXYD2 (gamma), FXYD3 (MAT-8), FXYD4 (CHIF), and FXYD5 (RIC) have been shown to induce channel activity in experimental expression systems. Transmembrane topology has been established for two family members (FXYD1 and FXYD2), with the N-terminus extracellular and the C-terminus on the cytoplasmic side of the membrane. This gene product, FXYD5, is a glycoprotein that functions in the up-regulation of chemokine production, and it is involved in the reduction of cell adhesion via its ability to down-regulate E-cadherin. It also promotes metastasis, and has been linked to a variety of cancers. Alternative splicing results in multiple transcript variants. [RefSeq curation by Kathleen J. Sweadner, Ph.D., sweadner@helix.mgh.harvard.edu., Sep 2009]. * **UniProt Summary**: Involved in down-regulation of E-cadherin which results in reduced cell adhesion. Promotes metastasis. {ECO:0000269|PubMed:11756660}. |ATP1G1 PLM MAT8| |negative regulation of calcium-dependent cell-cell adhesion| |regulation of calcium-dependent cell-cell adhesion| |ion channel regulator activity| |microvillus assembly| |microvillus organization| |sodium channel regulator activity| |regulation of sodium ion transmembrane transporter activity| |regulation of sodium ion transmembrane transport| |regulation of sodium ion transport| |negative regulation of cell-cell adhesion| |regulation of ion transmembrane transporter activity| |regulation of transmembrane transporter activity| |actin binding| |negative regulation of cell adhesion| |regulation of transporter activity| |cadherin binding| |regulation of cation transmembrane transport| |regulation of metal ion transport| |regulation of cell-cell adhesion| |plasma membrane bounded cell projection assembly| |cell projection assembly| |regulation of ion transmembrane transport| |regulation of transmembrane transport| |regulation of cell adhesion| |regulation of ion transport| |plasma membrane bounded cell projection organization| |cell projection organization| |ion transport| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp515|PU-H71 1μM R08 exp515]]|-2.04| |[[:results:exp261|ABT-702 5μM R06 exp261]]|-1.94| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.76| |[[:results:exp35|TRAIL 5ng/ml R00 exp35]]|-1.73| |[[:results:exp346|CoCl2 18μM R07 exp346]]|1.75| |[[:results:exp30|Rapamycin 10μM R00 exp30]]|1.76| |[[:results:exp439|QNZ 0.01μM R08 exp439]]|1.77| |[[:results:exp183|IU1-C 25μM R04 exp183]]|1.85| |[[:results:exp143|Phenformin 20μM R03 exp143]]|1.88| |[[:results:exp241|QNZ 0.01μM R05 exp241]]|2.28| |[[:results:exp426|FBS-Wisent 0.1 R07 exp426]]|2.38| |[[:results:exp210|LB-100 2μM R05 exp210]]|2.59| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9589 * **Expression level (log2 read counts)**: 5.43 {{:chemogenomics:nalm6 dist.png?nolink |}}